Overview

Effects of Administration of Fostamatinib on Blood Concentrations of Rifampicin in Healthy Subjects.

Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the drug interaction between fostamatinib and rifampicin by comparing the safety, tolerability and plasma concentration of fostamatinib when administered alone and with rifampicin in healthy subjects
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Rifampin